E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/3/2004 in the Prospect News Convertibles Daily.

IVAX greenshoe exercised, raising convertibles to $400 million

New York, March 3 - IVAX Corp. said the underwriters of its offering of senior convertible notes due 2024 exercised the $50 million over-allotment option in full, raising the size of the deal to $400 million.

The Miami pharmaceutical company originally sold $350 million of the securities after the market closed on Feb. 26 to yield 1.5% with a 26% initial conversion premium.

UBS Investment Bank was bookrunner for the Rule 144A offering.

IVAX said it will use "a significant portion" of the proceeds to redeem its 5.5% convertible senior notes due 2007. Remaining proceeds will be used for general corporate purposes. IVAX had $249.0 million of the 5.5% convertibles outstanding as of Dec. 31, 2003.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.